Prestige Consumer Healthcare Inc. (NYSE:PBH) Stock Holdings Lifted by XTX Topco Ltd

XTX Topco Ltd increased its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 354.0% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 22,778 shares of the company's stock after buying an additional 17,761 shares during the quarter. XTX Topco Ltd's holdings in Prestige Consumer Healthcare were worth $1,958,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the stock. GAMMA Investing LLC raised its stake in Prestige Consumer Healthcare by 35.9% during the 1st quarter. GAMMA Investing LLC now owns 1,879 shares of the company's stock valued at $162,000 after acquiring an additional 496 shares in the last quarter. KBC Group NV increased its holdings in shares of Prestige Consumer Healthcare by 7.4% during the first quarter. KBC Group NV now owns 2,199 shares of the company's stock valued at $189,000 after purchasing an additional 151 shares during the period. QRG Capital Management Inc. raised its stake in shares of Prestige Consumer Healthcare by 8.6% during the first quarter. QRG Capital Management Inc. now owns 5,971 shares of the company's stock valued at $513,000 after purchasing an additional 475 shares in the last quarter. Norges Bank acquired a new stake in Prestige Consumer Healthcare in the fourth quarter worth about $40,009,000. Finally, BNP Paribas Financial Markets grew its position in Prestige Consumer Healthcare by 1,073.3% in the 4th quarter. BNP Paribas Financial Markets now owns 203,903 shares of the company's stock valued at $15,923,000 after buying an additional 186,524 shares in the last quarter. 99.95% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts have commented on the stock. Wall Street Zen upgraded shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. Royal Bank Of Canada upgraded shares of Prestige Consumer Healthcare to a "hold" rating in a report on Thursday, May 8th. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, Prestige Consumer Healthcare has a consensus rating of "Moderate Buy" and a consensus target price of $93.33.

Prestige Consumer Healthcare Price Performance

NYSE PBH traded down $0.22 on Friday, reaching $73.73. The company's stock had a trading volume of 423,917 shares, compared to its average volume of 367,855. Prestige Consumer Healthcare Inc. has a twelve month low of $64.94 and a twelve month high of $90.04. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.82 and a current ratio of 4.20. The firm's 50 day moving average is $80.89 and its two-hundred day moving average is $82.28. The stock has a market cap of $3.64 billion, a PE ratio of 17.19, a PEG ratio of 2.25 and a beta of 0.43.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.30 by $0.02. The business had revenue of $296.52 million during the quarter, compared to analyst estimates of $289.36 million. Prestige Consumer Healthcare had a net margin of 18.86% and a return on equity of 12.87%. The business's quarterly revenue was up 7.0% on a year-over-year basis. During the same period in the prior year, the business earned $1.02 earnings per share. As a group, sell-side analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.